The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Infections, not eosinophilic inflammation, are the primary cause of asthma exacerbations in patients receiving benralizumab.

A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.

Studies suggesting a link between COVID-19 vaccination and improved outcomes with ICIs may be driven by pandemic-era confounding and selection bias.

Many young adults lack a primary care provider and utilize urgent care clinics for nonemergency issues instead of scheduling routine checkups.

For adults with long COVID-related cognitive impairment, individualized, goal-oriented cognitive rehabilitation leads to sustained improvements in goal attainment.

Implementation of a rapid molecular pneumonia panel is associated with earlier antimicrobial optimization among critically ill patients with pneumonia.

Maternal SARS-CoV-2 infection during pregnancy does not significantly alter early childhood neurodevelopmental outcomes in a meta-analysis.

Twenty-four weeks of bepirovirsen achieves a functional cure in approximately one-fifth of patients with chronic hepatitis B.

Provisional CDC data indicate that the overall US death rate decreased across all age groups, reaching the lowest recorded level.

Patients hospitalized for WNV frequently experience physical and mental long-term sequelae 2 years after hospital discharge.

New sedative prescriptions for sedative-naive older adults post-discharge are associated with an increased risk for falls and death.